Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

2 terminated/withdrawn out of 18 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
6(40.0%)
Phase 2
5(33.3%)
Phase 1
3(20.0%)
Phase 4
1(6.7%)
15Total
N/A(6)
Phase 2(5)
Phase 1(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT05483465Phase 4Recruiting

The Effect of NAD Supplementation on Brain Vascular Health in Aging

Role: collaborator

NCT04562831Not ApplicableActive Not Recruiting

The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.

Role: collaborator

NCT06853743Phase 2Recruiting

The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease

Role: collaborator

NCT05095571Not ApplicableRecruiting

A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study

Role: collaborator

NCT06162013Phase 2Recruiting

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Role: collaborator

NCT04342975Phase 2Completed

Protection From Acute Kidney Injury (AKI) With Basis™ Treatment

Role: collaborator

NCT06333301Not Yet Recruiting

Translational Initiative to Map Epigenetics in Sleep

Role: lead

NCT04990869Not ApplicableCompleted

Inflammation in COPD and the Effect of Nicotinamide Riboside

Role: collaborator

NCT05593939Phase 2Completed

Slow Age: Interventions to Slow Aging in Humans

Role: collaborator

NCT05760547Not Yet Recruiting

The Translational Initiative to Map Epigenetics in Aging (TIME-A)

Role: lead

NCT04220658Suspended

Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers

Role: lead

NCT04050358Phase 1Withdrawn

Effect of Basis™ and High Intensity Interval Training (HIIT) on Muscle Metabolism and Exercise Performance

Role: lead

NCT04407390Phase 2Withdrawn

Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly

Role: collaborator

NCT03513523Not ApplicableCompleted

Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers

Role: lead

NCT03635411Phase 1Unknown

Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)

Role: lead

NCT03176628Not ApplicableCompleted

Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study

Role: collaborator

NCT03489200Not ApplicableCompleted

EH301 for the Treatment of ALS

Role: lead

NCT02678611Phase 1Completed

A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.

Role: lead

All 18 trials loaded